Causal relationship between immune cells and atrial fibrillation: A Mendelian randomization study

• Published in: Medicine (Baltimore) 2024-05, Vol.103 (19), p.e38079-e38079
• Main Authors: Chu, Haoxuan, Guo, Xia, Xu, Hanchi, Wang, Shipeng, He, Jiahuan, Wang, Yushi
• Format: Article
• Language: English
• Subjects: Atrial Fibrillation - epidemiology; Atrial Fibrillation - genetics; Atrial Fibrillation - immunology; B-Lymphocytes - immunology; Humans; Interleukin-2 Receptor alpha Subunit - genetics; Mendelian Randomization Analysis; Observational Study; Risk Factors
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000038079

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia, with recent research indicating a correlation between immune system characteristics and the development of AF. However, it remains uncertain whether the immunological response is the primary underlying component or a secondary consequence of AF. Initially, we investigated the effect of immune cells on AF by performing forward Mendelian randomization (MR) analyses with immune cells as the exposure variable and their associated genetic variants as instrumental variables. Subsequently, we performed reverse MR analyses with AF as the exposure variable and immune cells as the outcome variable to exclude the interference of reverse causality, to distinguish between primary and secondary effects, and to further elucidate the causal relationship between the immune system and AF. We discovered that membrane proteins on specific immune cells, such as CD25 on memory B cells-which functions as a part of the interleukin-2 receptor-may be risk factors for AF development, with odds ratios of 1.0233 (95% confidence interval: 1.0012-1.0458, P = .0383). In addition, certain immune cell counts, such as the CD4 regulatory T cell Absolute Count, play a protective factor in the development of AF (odds ratio: 0.9513, 95% confidence interval: 0.9165-0.9874; P = .0086). More detailed results are elaborated in the main text. Our MR study has yielded evidence that substantiates a genetically inferred causal association between the immune system and AF. Identifying the risk factors associated with AF is vital to facilitate the development of innovative pharmaceutical treatments.